Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCRAMBLED EGGS
NCT02087826Active, not recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2014
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Response to the Mixed Meal Tolerance Test. Started Apr 2014; status: active, not recruiting.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02087826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02087826.